Effectively Manage and Leverage Advanced Data Analytics to Improve Patient-Centered Outcomes and Adopt a Value-Based Treatment Paradigm
As the pharmaceutical industry strives to extract meaningful insight, value and outcomes from their data analytics, pharma and biotech are experiencing a significant movement towards real-world evidence to power the advanced decision-making that optimizes patient-centric approaches.
This evolution has led to a fresh focus for the 4th Annual Advanced Pharma Analytics Summit (formerly know as Big Data in Pharma). Join the industry to learn about the successful application of advanced data analytics tools, including big data and predictive analytics, to progress products in the late stages of their life cycle. This year’s summit will also highlight the significant opportunities present within real-world evidence as it is used to compliment clinical trial data and to accelerate regulatory approval and post-approval evidence.
The 4th APA Summit 2016 will showcase the latest case studies from the likes of Genentech, Pfizer, Novartis and the FDA that demonstrate value and tangible ROI derived from effective data sourcing, standardization, integration, infrastructure, real-world evidence and advanced analytics. Discover the right technology, tools and customized analytics capabilities you need to make improved data-driven decisions that optimize health economics, market access, pricing and reimbursement strategies.
Join the Advanced Pharma Analytics community to fully realize and extract the right value and insight you need from your data and real-world evidence.
"This is a great event! Something that provides a much needed direction to the Big Data community."
"It was a very helpful meeting and I was glad to share some of our current methods of data analytics with the others present at the occasion."